1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Systemic Scleroderma: new trials by email Literature Review of Systemic Scleroderma trials Research Report on Systemic Scleroderma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis fludarabine phosphate, total-body irradiation, tacrolimus - Systemic Scleroderma | Phase 2 | Withdrawn | Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium | 2012-10-31 |
Scleroderma, Diffuse (1) · Scleroderma, Systemic (1)
Connective Tissue Diseases (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Cyclophosphamide (1) · Mycophenolic Acid (1) · Peripheral Blood Stem Cell Transplantation (1) · Rituximab (1) · Tacrolimus (1) · Whole-Body Irradiation (1) · fludarabine phosphate (1)
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)
United States (1)
George Georges (1)